
Chad Bronstein, CEO and Founder of Fyllo
by Nick Opich on May 6, 2021 in podcast
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
by Nick Opich on May 6, 2021 in podcast
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Chad Bronstein, CEO and Founder of Fyllo (pronounced Fee-Low), a technology company delivering data, media, and regulatory solutions to the cannabis industry. Under Chad’s leadership, Fyllo has revolutionized marketing technology for highly-regulated industries, allowing the most ambitious cannabis, CBD and consumer brands to overcome the complexities of compliance at-scale.
Our hosts sat down with Chad about the current regulatory challenges the industry faces, how the COVID pandemic has affected his business and Chad makes some bold predictions on what may happen with the SAFE Banking Act. We also learn more about Fyllo’s suite of software solutions that are aiding companies from startups to Uber navigate the cannabis space as well as Chad’s endeavors into the psychedelic space with Wesana Health.
Don’t sit back, lean forward and enjoy!
Chad Bronstein, CEO and Founder of Fyllo
Chad Bronstein founded Fyllo with the expertise gained during a career leading the sales and marketing teams of some of the largest businesses in advertising, media, and technology. His experience leading large-scale acquisitions, venture fundraising, strategic partnerships, and corporate exits has resulted in the scaling of several startups into national leaders. Under Chad’s leadership, Fyllo has revolutionized marketing technology for highly-regulated industries, allowing the most ambitious cannabis, CBD and consumer brands to overcome the complexities of compliance at-scale. Since founding Fyllo in 2019, Chad has overseen the product development, marketing, capital raising, and M&A deals that have uniquely positioned Fyllo to solve the challenges of these fragmented and inefficient markets.
Links and mentions in the show
Links to the guest’s company and social media accounts
Show Credits:
This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.
Special thanks to our Program Director Shea Gunther.
You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:
Twitter: @The_GreenRush
Instagram: @thegreenrush_podcast
LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/
Facebook: https://www.facebook.com/TheGreenRushPodcast/
YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Lewis Goldberg and Anne Donohoe are back for a new episode with special guest Ken Jordan, CEO, Co-Founder and Editorial Director of Lucid News. Ken joins us this week […]
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Emmaline Lewis are back for a new episode with special guest Dr. Dennis McKenna, Ethnopharmacologist and the Director and President of the McKenna Academy of Natural […]
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Nick Opich are back for a new episode with special guest Jess Tyler, Chief Revenue and Experience Officer at MJBiz and MJBizCon. Jess joins us this […]
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Nick Opich and Lewis Goldberg are back for a new episode with special guest Brigadier General (Ret.) Stephen N. Xenakis, MD, Executive Director of the American Psychedelic Practitioners Association […]